News
International collaboration identifies new breast cancer susceptibility genes
17 Aug 2023
The study, published today in Nature Genetics, was led by teams at the University of Cambridge and Université Laval, Quebec.
Radiotherapy boost cuts treatment time for breast cancer patients by at least a week
3 Jul 2023
Treatment times for radiotherapy could be reduced for some early breast cancer patients, according to a trial led by Professor Charlotte Coles and funded by Cancer Research UK.
Most women diagnosed with early breast cancer today will beat the disease
13 Jun 2023
Waterbeach woman involved in the study welcomes results.
Centre members elected to Academy of Medical Sciences 2023
18 May 2023
Congratulations to Charlotte Coles, Eric Miska and Serena Nik-Zainal who have been elected to the Academy of Medical Sciences Fellowship.
A step closer to precision cancer treatment
6 Apr 2023
We welcome the NHS landmark deal approving targeted drug olaparib to treat two most common cancers.
Junior Investigators attend Leicester meeting
8 Feb 2023
Annual Junior Investigators Network Group meeting held in Leicester on 6 and 7 Feb 2023
First UK proton beam therapy trial for breast cancer launches
4 Jan 2023
A pioneering trial will determine potential benefits of proton beam therapy compared with standard radiotherapy for people at greater risk of developing long-term heart problems following radiotherapy.
Technique for tracking resistant cancer cells could lead to new treatments for relapsing breast cancer patients
19 Dec 2022
Cambridge scientists have managed to identify and kill those breast cancer cells that evade standard treatments in a study in mice. The approach is a step towards the development of new treatments to prevent relapse in patients.
Cambridge Precision Breast Cancer Symposium
30 Nov 2022
The Cambridge Precision Breast Cancer Symposium will take place on Friday 10 February 2023 at Clare College, Cambridge.
Cambridge and Kolkata breast cancer researchers exchange ideas
2 Nov 2022
A meeting between Tata Medical Center Kolkata, RadNet Cambridge and our Precision Breast Cancer Institute highlights areas for collaboration.